Please assess the completion status of the following clinical trial:

Trial Title: 18F-FTC-146 PET/CT in Newly-Diagnosed Osteosarcoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with biopsy proven osteosarcoma requiring local surgical intervention.~* ECOG ≤ 2~* Ability to understand and the willingness to sign a written informed consent document.~Exclusion Criteria:~* Chemotherapy in the past 2 months.~* Prior history of allergic reaction to 18F FTC 146.~* Pregnant or nursing

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 18-F-FTC 146 PET/CT (Type: EXPERIMENTAL): For PET scans, subjects will receive intravenous injection of 10 mCi 18-F -FTC 146 administered twice with 18-F-FTC 146, once at baseline (pre chemotherapy) and once at final study visit (post chemotherapy).

Based on this trial design, predict the completion outcome and termination type (if applicable).